Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
JAMA Neurology|June 16, 2020
Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled TrialRadu Tanasescu, Christopher R Tench, Cris S Constantinescu, et al.Neuro-Oncology Advances|January 6, 2022
Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.Neuro-Oncology Advances|May 5, 2021
ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.Oncotarget|February 9, 2018
Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancerDavid Onion, Mark Isherwood, Naveen Shridhar, et al.Rheumatology (Oxford, England)|October 17, 2022
Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccinationLeher Gumber, Nancy Gomez, Georgina Hopkins, et al.Journal of the American Chemical Society|July 4, 2023
Platform Reagents Enable Synthesis of Ligand-Directed Covalent Probes: Study of Cannabinoid Receptor 2 in Live CellsMiroslav Kosar, David A Sykes, Alexander E G Viray, et al.Molecular Cancer Therapeutics|February 14, 2016
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase InhibitorsDavid Onion, Richard H Argent, Alexander M Reece-Smith, et al.Journal of Clinical Immunology|June 10, 2024
Lower Humoral and Cellular Immunity Following Asymptomatic SARS-CoV-2 Infection Compared to Symptomatic Infection in Education (The ACE Cohort)Georgina Hopkins, Nancy Gomez, Davis Tucis, et al.Pageof 4